WHO seeks to calm nerves on AstraZeneca


German Health Minister Jens Spahn tells a news conference in Berlin on Monday that the country is suspending the use of the AstraZeneca vaccine. JOHN MACDOUGALL/AGENCE FRANCE-PRESSE

Reports of blood clots don't warrant halt to vaccine's use, health body says

The World Health Organization said countries should continue to administer the AstraZeneca vaccine against COVID-19 after more European countries suspended its use following reports of blood clots among people inoculated.

On Tuesday, Sweden became the latest country to pause use of Astra-Zeneca's vaccine.

The day before, France announced a halt in jabs with the vaccine until at least Tuesday afternoon, and Germany decided for an indefinite suspension. Spain, Luxembourg, Portugal, Slovenia and Cyprus also that day put the shots on hold.

French President Emmanuel Macron, who earlier questioned the vaccine's efficacy, said on Monday that his decision is a "precautionary measure" pending further guidance from the European Medicines Agency, or EMA.

German Health Minister Jens Spahn told a news conference: "In the light of these newly reported cases, the Paul Ehrlich Institute today reassessed the situation and recommended a suspension of the vaccination and further investigations."

The institute is Germany's federal medical regulator.

EMA Executive Director Emer Cooke said on Tuesday afternoon that its experts met earlier in the day and will carry on with investigations and meet again on Thursday to come to a conclusion based on the full information gathered.

WHO Director-General Tedros Adhanom Ghebreyesus said on Monday that the suspensions of the AstraZeneca vaccine do not necessarily mean the reported blood clots are linked to vaccinations.

"But it's routine practice to investigate them, and it shows that the surveillance system works and that effective controls are in place," he told a virtual news conference.

Tedros said the WHO's Advisory Committee on Vaccine Safety has been reviewing the data and is in close contact with the EMA, including with a meeting on Tuesday.

Mariangela Simao, the WHO's assistant director-general for access to medicines, vaccines and pharmaceuticals, said the agency has been working with health regulators in Europe and other regions in assessing not only the reports regarding the AstraZeneca vaccine, but all the adverse effects from other vaccines. She expects more news related to the AstraZeneca shot to be announced in the coming days.

WHO Chief Scientist Soumya Swaminathan said people need to look at the benefits versus the risks, saying that "no drug or vaccine would ever be 100 percent" safe.

Monitoring required

The Indian scientist said that of the 300 million doses of various vaccines given to people so far, "there is no documented death that has been linked to a COVID vaccine".

"I think that while we need to continue to be very closely monitoring this, we do not need people to panic," she said.

"We would for the time being recommend that countries continue vaccinating with AstraZeneca," she said.

Denmark was the first country to suspend the rollout of the vaccine last Thursday after reports of blood clots.

The EMA on Monday noted that many thousands of people develop blood clots every year in the EU for various reasons, and the number of such events overall in vaccinated people doesn't seem to be higher than that seen in the general population.

AstraZeneca said on Sunday that a review of the safety data has not shown any evidence of an increased risk of blood clots.

德国卫生部长延斯·斯帕恩周一在柏林的新闻发布会上表示,德国将暂停使用阿斯利康疫苗。约翰·麦克杜格尔/法新社报道称,血凝块并不能保证停止疫苗的使用,健康组织称,在更多欧洲国家因接种人群中出现血凝块的报道而停止使用阿斯利康疫苗后,世界卫生组织称各国应继续对新冠肺炎使用阿斯利康疫苗。周二,瑞典成为暂停使用阿斯特拉-捷利康疫苗的最新国家。前一天,法国宣布至少在周二下午之前停止接种疫苗,德国决定无限期暂停接种。西班牙、卢森堡、葡萄牙、斯洛文尼亚和塞浦路斯当天也暂停了比赛。法国总统埃马纽埃尔·马克龙早些时候质疑疫苗的效力,他周一表示,他的决定是一项“预防措施”,有待欧洲药品管理局(EMA)的进一步指导。德国卫生部长延斯·斯帕恩在新闻发布会上说:“鉴于这些新报告的病例,保罗·埃尔利希研究所今天重新评估了情况,并建议暂停疫苗接种和进一步调查。”该研究所是德国的联邦医疗监管机构。EMA执行董事Emer Cooke周二下午表示,其专家在当天早些时候举行了会议,并将继续进行调查,并在周四再次会面,根据收集的全部信息得出结论。世卫组织总干事特德罗斯·阿德哈诺姆·格布雷耶斯周一表示,阿斯利康疫苗的暂停并不一定意味着报告的血凝块与疫苗接种有关。“但调查他们是常规做法,这表明监控系统是有效的,有效的控制是到位的,”他在一次虚拟新闻发布会上说。特德罗斯说,世卫组织疫苗安全咨询委员会一直在审查数据,并与欧洲药品管理局密切接触,包括周二的一次会议。世卫组织负责药品、疫苗和药品获取的助理总干事玛丽安杰拉·西芒(Mariangela Simao)表示,该机构一直在与欧洲和其他地区的卫生监管机构合作,不仅评估关于阿斯利康疫苗的报告,还评估其他疫苗的所有不利影响。她预计未来几天将公布更多与阿斯利康枪击案有关的消息。世卫组织首席科学家苏米亚·斯瓦米纳坦说,人们需要考虑利弊,他说“没有任何药物或疫苗是100%安全的”。这位印度科学家说,在迄今为止给予人们的3亿剂各种疫苗中,“没有记录在案的死亡与COVID疫苗有关”。“我认为,尽管我们需要继续非常密切地监测这一点,但我们不需要人们恐慌,”她说。“我们暂时建议各国继续接种阿斯利康,”她说。上周四,丹麦是第一个在有血凝块报告后暂停推出疫苗的国家。EMA周一指出,在欧盟,每年有成千上万的人因各种原因出现血凝块,接种疫苗的人总体上发生这种事件的数量似乎并没有高于普通人群。阿斯利康周日表示,对安全数据的审查没有显示任何血栓风险增加的证据。

上海久汇纺织科技有限公司

公司总机:021-58991190

产品供应部:

18049721407 梁工

http://www.starpont.com 

EMAIL:

starpont@126.com

  • 申久集团第五届十二次董事会在上海顺利召开
    2021年9月16日下午,申久集团第五届董事会第十二次会议在上海展览中心顺利召开。申久集团董事会成员出席了本次会议,申久集团监事会成员、公司高层领导列席了本次会议,会议由申久集团董事长黄建春主持。
  • 申久集团举行消防事故应急演练活动
    为认真贯彻执行“安全第一、预防为主、综合治理”的安全工作方针,规范公司应急管理工作,提高突发事件应急救援反应速度和协调水平,增强综合处置事故的能力,预防和控制次生灾害的发生,保障公司岗位员工和公众的生命安全,最大限度的减少财产损失、环境破坏和社会影响,结合近期周边地区安全生产事故频发的状况,我公司于2021年9月17日进行了成品库丝包着火事故应急演练活动。
  • “江苏申久•太仓逸枫篮球联谊赛”在申久顺利举行
    9月25日下午,秋高气爽,由申久集团工会、团委牵头组织的“江苏申久·太仓逸枫篮球联谊赛”,在申久宿舍区篮球场顺利举行。
  • 血浓情浓,爱融其中 —义务献血报道
    申久集团在注重企业发展的同时,肩负社会责任,为社会传递更多的爱心。
  • 喜讯 | 申久集团获颁“慈善爱心企业(单位)”荣誉
    申久集团获颁“慈善爱心企业(单位)”,这是对申久集团积极投身公益慈善事业的肯定,申久集团将以此为契机,积极承担更多的社会责任,积极发挥向上向善正能量。
  • 这!就是今日纺织 | 聚焦纺织服装业,《经济日报》报道:筑牢纺织工业强国根基
    中国纺织工业联合会会长孙瑞哲表示,“十四五”时期,是在世界百年未有之大变局下,中国推进全面建设社会主义现代化国家的战略机遇期,也是行业在基本实现纺织强国目标的基础上,围绕“科技、时尚、绿色”实现更高质量、更有效率、更加公平、更可持续、更为安全发展的重要窗口期。
  • 纺织非遗助力乡村振兴 巩固脱贫成果(央广网)
    手工刺绣蓝牙音箱、扎染单肩包、缠花技艺小饰品……在我国已公布的1300多项国家级非物质文化遗产代表性项目中,纺织类非遗项目多达百余项。近年来,纺织非遗融入现代生活与消费渐成风尚。
  • 申久集团开展安全宣讲及安全风险辨识培训活动
    为贯彻“安全第一、预防为主、综合治理”的安全生产工作方针,进一步增强企业员工的安全意识,根据《江苏省工业企业风险报告规定》(省政府令第140号)等相关文件要求以及璜泾镇安全工作部署要求,申久集团组织安全管理人员开展了一次安全宣讲及安全风险辨识培训活动。
  • 省财贸轻纺工会领导莅临申久考察调研
    6月11日上午,省财贸轻纺工会二级调研员陈树礼等一行7人,在太仓市总工会副主席徐昭君、璜泾镇副镇长姚巍峰等领导的陪同下,莅临申久公司进行调研工作,申久集团副总裁邱国全、工会主席刘亚东进行了热情接待。